TREM2 and Alzheimer disease: The gene TREM2, which is exclusively expressed by microglia in the brain, has been found to regulate inflammatory signaling, as well as sustain the proliferation and survival of microglia.[103, 104] This renders TREM2 a promising target for AD treatment.